Front Line Medical Technologies yesterday said it received Health Canada approval for its COBRA-OS arterial occlusion system. The COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) is designed to be extremely low-profile for temporary hemorrhage control and resuscitation. “Even with all the advances in medicine today, … [Read more...] about Front Line Medical wins Health Canada approval for arterial occlusion system
Implants
Cardiovascular Systems, Chansu Vascular Technologies partner to develop drug-coated balloons
Cardiovascular Systems recently announced that it has partnered with Chansu Vascular Technologies to develop a new drug-coated balloon technology. Through the partnership, Cardiovascular Systems and Chansu Vascular Technologies will develop peripheral and coronary everolimus drug-coated balloons. Cardiovascular Systems will provide … [Read more...] about Cardiovascular Systems, Chansu Vascular Technologies partner to develop drug-coated balloons
The top 10 catheter innovations of 2020
As the COVID-19 pandemic took over the world in 2020, medical device companies continued to showcase new catheter innovations. Throughout 2020, we saw FDA clearances, approvals and product launches for a variety of catheter-based technologies, including renal denervation systems, heart failure treatment catheters, mechanical thrombectomy systems … [Read more...] about The top 10 catheter innovations of 2020
What is the difference between thermoplastics, thermosets and elastomers?
by International Polymer Engineering Plastics that are both strong and lightweight improve the safety, performance and convenience of a wide variety of products that we all use every single day. Plastics consist mainly of macromolecules that are processed into molded parts, films, fibers or finished/semi-finished products. The specific … [Read more...] about What is the difference between thermoplastics, thermosets and elastomers?
Acutus Medical transseptal crossing wins CE mark
Acutus Medical today said it received CE mark approval for its transseptal crossing products. The device is designed to deliver safe and efficient access to the left atrium of the heart. It includes the company's AcQCross Qx with either the AcQGuide Mini or steerable AcQGuide Flex introducer sheath. AcQCross Qx features an integrated needle … [Read more...] about Acutus Medical transseptal crossing wins CE mark
Medical Ingenuities gains FDA nod for radial artery occlusion device
Medical Ingenuities today received FDA 510(k) clearance for its radial artery occlusion device called PH Band. PH Band provides real-time feedback to medical personnel monitoring radial artery patency to help prevent radial artery occlusion. It can be used in conjunction with a micro Doppler Probe to achieve patent hemostasis after a minimally … [Read more...] about Medical Ingenuities gains FDA nod for radial artery occlusion device
Boston Scientific throws in the towel on Lotus TAVR
Boston Scientific (NYSE:BSX) announced today that it has initiated a global, voluntary recall of its Lotus Edge aortic valve system — and is immediately retiring the Lotus program. Marlborough, Mass.-based Boston Scientific said in a news release that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) … [Read more...] about Boston Scientific throws in the towel on Lotus TAVR
FDA approves Boston Scientific’s Ranger drug-coated balloon
Boston Scientific (NYSE:BSX) today said it received FDA approval for its Ranger drug-coated balloon for peripheral artery disease. The balloon's creators designed it to treat peripheral artery disease (PAD) in the superficial femoral artery and proximal popliteal artery — with a low therapeutic drug dose and coating to transfer the drug into the … [Read more...] about FDA approves Boston Scientific’s Ranger drug-coated balloon
LeMaitre Vascular up on Street-beating Q3 results
LeMaitre Vascular (NSDQ:LMAT) posted third-quarter results that beat the consensus forecast on Wall Street. The Burlington, Mass.-based company reported profits of $7.5 million, or 37¢ per share, on sales of $36.4 million for the three months ended Sept. 30, for a bottom-line gain of 44.9% sales growth of 25.1% compared with Q3 2019. Get the … [Read more...] about LeMaitre Vascular up on Street-beating Q3 results
Olympus launches esophagus through-the-scope stent
Olympus today announced it commercially launched its Hanarostent esophagus TTS self-expanding metal stents. The through-the-scope esophageal stent helps with luminal patency in a variety of clinical applications. It is designed for use in the palliative treatment of esophageal stricture or trachea-esophageal fistula caused by malignant … [Read more...] about Olympus launches esophagus through-the-scope stent
